[go: up one dir, main page]

DE10390418D2 - Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen - Google Patents

Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen

Info

Publication number
DE10390418D2
DE10390418D2 DE2003190418 DE10390418T DE10390418D2 DE 10390418 D2 DE10390418 D2 DE 10390418D2 DE 2003190418 DE2003190418 DE 2003190418 DE 10390418 T DE10390418 T DE 10390418T DE 10390418 D2 DE10390418 D2 DE 10390418D2
Authority
DE
Germany
Prior art keywords
microorganisms
production
recombinant proteins
recombinant
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE2003190418
Other languages
English (en)
Inventor
Rudy Susilo
Hans Christian Korting
Hans Guenther Gassen
Martin Hils
Ralf Pasternack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
N Zyme Biotec GmbH
Original Assignee
N Zyme Biotec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N Zyme Biotec GmbH filed Critical N Zyme Biotec GmbH
Priority claimed from PCT/DE2003/000341 external-priority patent/WO2003066842A2/de
Application granted granted Critical
Publication of DE10390418D2 publication Critical patent/DE10390418D2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE2003190418 2002-02-06 2003-02-06 Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen Expired - Fee Related DE10390418D2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02002716 2002-02-06
US35780902P 2002-02-21 2002-02-21
PCT/DE2003/000341 WO2003066842A2 (de) 2002-02-06 2003-02-06 Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen

Publications (1)

Publication Number Publication Date
DE10390418D2 true DE10390418D2 (de) 2005-01-13

Family

ID=27736039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2003190418 Expired - Fee Related DE10390418D2 (de) 2002-02-06 2003-02-06 Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen

Country Status (2)

Country Link
US (1) US20050124036A1 (de)
DE (1) DE10390418D2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1740698T3 (da) * 2004-04-22 2010-10-25 Talecris Biotherapeutics Inc Rekombinant modificeret plasmin
US20070134230A1 (en) * 2005-12-13 2007-06-14 Jani Dharmendra M Method for prolonging activity of autodegradable enzymes
US20070134231A1 (en) * 2005-12-13 2007-06-14 Jani Dharmendra M Method for prolonging activity of autodegradable enzymes and compositions thereof
US20070196350A1 (en) * 2006-02-22 2007-08-23 Bartels Stephen P Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment
US20070212358A1 (en) * 2006-03-10 2007-09-13 Bartels Stephen P Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment
HUE024916T2 (en) * 2007-11-29 2016-02-29 Grifols Therapeutics Inc Recombinantly modified plasmin
EP2249863A4 (de) * 2008-01-22 2011-12-28 Omnio Healer Ab Verfahren zur verbesserung der wundheilung
KR20160110544A (ko) * 2008-06-04 2016-09-21 그리폴스 테라퓨틱스 인코포레이티드 플라스민의 제조를 위한 조성물, 방법 및 키트
PL2403865T3 (pl) 2009-03-03 2016-01-29 Grifols Therapeutics Inc Sposoby wytwarzania plazminogenu
WO2010116809A1 (ja) * 2009-04-07 2010-10-14 Anbe Yoshinobu Ｘ線検査用加熱装置
US9528116B2 (en) * 2009-10-30 2016-12-27 Merck Sharp & Dohme Corp. Method for producing therapeutic proteins in Pichia pastoris lacking dipeptidyl aminopeptidase activity
CN110114079A (zh) 2016-12-15 2019-08-09 泰伦基国际有限公司 一种预防和治疗肥胖症的方法和药物
CA3047168A1 (en) 2016-12-15 2018-06-21 Talengen International Limited Method for treating coronary atherosclerosis and complications thereof
CN110114081A (zh) * 2016-12-15 2019-08-09 泰伦基国际有限公司 一种改善心脏病变的方法
CA3047174A1 (en) 2016-12-15 2018-06-21 Talengen International Limited Method for preventing and treating liver fibrosis
CA3067890A1 (en) 2017-06-19 2018-12-27 Talengen International Limited Method for regulating and controling glp-1/glp-1r and drug
CN110204608B (zh) * 2019-05-10 2020-03-20 美尔健（深圳）生物科技有限公司 一种酵母发酵小分子重组纤连蛋白肽及其制备方法和应用
EP4251195A1 (de) * 2020-11-25 2023-10-04 Grifols Worldwide Operations Limited Wundheilung
CN118146354B (zh) * 2024-03-05 2024-12-03 江苏创健医疗科技股份有限公司 重组vii型胶原蛋白及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
US5688664A (en) * 1990-12-07 1997-11-18 British Bio-Technology Ltd. Thrombin activatable plasminogen analogues
US5520912A (en) * 1993-07-02 1996-05-28 Immuno Aktiengesellschaft Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen
AU2002218890A1 (en) * 2000-12-21 2002-07-01 Thromb-X N.V. A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell

Also Published As

Publication number Publication date
US20050124036A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
DE502004001613D1 (de) Verfahren zur herstellung von polyamiden
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE602005016292D1 (de) Verfahren zur herstellung von glatiramer
DE60236431D1 (de) Verfahren zur herstellung von olefinen
DE60303984D1 (de) Verfahren zur Herstellung von Polyesterharzen
DE60333291D1 (de) Verfahren zur herstellung von flachglas
DE60321625D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60222645D1 (de) Verfahren zur herstellung von oxazolidinonen
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
DE60331571D1 (de) Verfahren zur herstellung von poröser wabenstruktur und wabenkörper
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
DE60201498D1 (de) Verbesserter prozess zur herstellung von carbapenemen
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
EP1668125A4 (de) Modifizierte enzyme, verfahren zur herstellung modifizierter enzyme und verwendungen davon
DE60321626D1 (de) Verfahren zur Herstellung von Acrylsäure
DE602004007212D1 (de) Verfahren zur Herstellung von hochwertigen fermentierten Sojabohnenprodukten
DE60204334D1 (de) Verfahren zur herstellung von repaglinide
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE60220554D1 (de) Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen
DE60315741D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60239085D1 (de) Prozess zur Herstellung von E-Caprolactam
DE50305250D1 (de) Verfahren zur Herstellung von Polyurethan-Formteilen
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE60217249D1 (de) Verfahren zur Herstellung von pressgeformten Gegenständen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee